Nu Skin Enterprises, Inc. (NUS) stock analysis

P/E against its history

Not enough price and earnings history to compare.

P/E against the industry

Needs positive earnings and enough profitable companies in the industry.

EV/EBITDA above its 5-year median

Nu Skin Enterprises's EV/EBITDA of 9.6 is above its 5-year median of 8.0.

P/B below the industry

Nu Skin Enterprises's price-to-book of 0.35 is below the Wholesale Trade-non-durable Goods median of 1.69.

Trading below fair value

The share price of $3.89 is below our fair value estimate of $13.01.

Margin of safety over 20%

The price is 70.1% below fair value, more than the 20% cushion we look for.

Revenue growing under 10% a year

Revenue grew -12.6% a year over the last three fiscal years, short of the 10% we look for.

EPS growing 10%+ a year

Diluted EPS grew 15.4% a year over the last three fiscal years.

Earnings growth not accelerating

Net income grew -314% over the last twelve months, against a 5-year average of -3.5% a year.

Growing slower than the industry

Revenue grew -15.3% over the last twelve months; the Wholesale Trade-non-durable Goods median is -5.1%.

Guidance issued

The latest outlook (Q3 2026 Revenue, Aug 10, 2026) was issued for the first time, so it neither adds nor takes away points.

Gross margin improving

Gross margin was 67.8% over the last twelve months, against 67.2% a year earlier.

Return on equity under 15%

Return on equity was -34.8% over the last twelve months and averaged 6.2% over five years; we look for 15% on both.

Return on capital under 10%

Return on invested capital was -3.1%, below the 10% that usually covers the cost of capital.

Return on equity below the industry

Nu Skin Enterprises's return on equity of -34.8% is below the Wholesale Trade-non-durable Goods median of -6.0%.

Earnings shrank over 5 years

Net income shrank 3.5% a year on average over the last five fiscal years.

Net margin below its 5-year average

Net margin was -17.7% over the last twelve months, against a 5-year average of 2.6%.

Net margin below the industry

Nu Skin Enterprises's net margin of -17.7% is below the Wholesale Trade-non-durable Goods median of -13.1%.

Low debt

Debt is 37.2% of shareholders' equity, under the 40% we consider low.

Debt falling against equity

Debt to equity fell from 37.5% five years ago to 37.2%.

Debt not well covered by cash flow

Operating cash flow over the last twelve months equals 7.5% of total debt; we look for at least 20%.

Interest not well covered

Operating income covers interest expense -1.8 times; we look for at least 5.

Short-term assets cover short-term debts

Current assets are 2.04 times current liabilities.

Low bankruptcy risk

The Altman Z-score is 3.68; above 3 is the safe zone and below 1.8 the distress zone.

Pays a dividend

Nu Skin Enterprises paid dividends worth 6.2% of the share price over the last twelve months.

Yield above Treasuries

The 6.2% yield is above the 4.4% on a 1-year Treasury.

Yield in the top quarter

The top quarter of US dividend payers yield 3.8% or more; Nu Skin Enterprises yields 6.2%.

Dividend stability

Fewer than five years of dividend history.

Earnings cover

Needs dividends paid and net income.

Cash-flow cover

Needs dividends paid and free cash flow.